Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healshape is developing a personalized, fully resorbable, and natural breast bioprosthesis using a proprietary 3D bioprinting technology. The implant acts as a scaffold that is colonized by the patient’s own cells via fat transfer, leading to natural breast tissue regeneration while the hydrogel scaffold gradually dissolves. No clinical results are yet available; preclinical development is ongoing with first-in-human trials anticipated in the near future.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healshape.